Long-Term skin treatment study seeks to confirm safety for eczema patients
NCT ID NCT06012812
Summary
This study followed 79 adults with moderate to severe atopic dermatitis (eczema) who had already participated in earlier research on the drug SHR-1819. The main goal was to gather more information on the long-term safety and effectiveness of the injection. Participants continued receiving the treatment to see how well it controlled their skin condition over a longer period and to monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital,Fudan University
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.